Michael has worked at the Burnet Institute since 2017, and is an epidemiologist and post-doctoral research officer in the HIV Prevention and Surveillance & Evaluation working groups. Michael’s research involves analysing large surveillance data to examine epidemiological trends in infectious diseases and evaluate large-scale public health interventions, with a particular focus on HIV and bacterial STIs.
Michael is also a Research Fellow at the Department of Population Medicine, Harvard Medical School in Boston, USA, where he works on a range of projects related to HIV prevention among key populations.
Michael completed his PhD at Burnet Institute in 2022, where he explored the interplay between HIV pre-exposure prophylaxis (PrEP) implementation and the epidemiology of bacterial STIs among gay and bisexual men in Australia.
Key research interests include: infectious disease epidemiology, disease surveillance, HIV & STI prevention, biostatistics and sexual health.
Open Forum Infectious Diseases
Michael W Traeger, Brendan Harney, Rachel Sacks‐Davis, Daniela K van Santen, Edwina Wright, Margaret Hellard, Joseph Doyle, Mark Stoové, Michael W Traeger, Brendan Harney
Open Forum Infectious Diseases
Michael W Traeger, Brendan Harney, Rachel Sacks‐Davis, Daniela K van Santen, Edwina Wright, Margaret Hellard, Joseph Doyle, Mark Stoové, Michael W Traeger, Brendan Harney
We're taking a multifaceted approach to HIV prevention and supporting the health and wellbeing of people living with HIV.
ACCESS is a national sentinel surveillance network of sexually transmissible infections and blood-borne viruses.
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.